Differential fracture risk in breast cancer patients based on endocrine therapy and age: a nationwide cohort study.

Osteoporos Int · 2025 · PMC12672634 · PMID 41091161

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may not be significantno p-value reported

Although this study did not reveal changes in bone density in patients with young breast cancer, bone density changes caused by the use of tamoxifen may not be significant enough to increase the risk of fracture.

also in 2,774 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.